D
Dana Panteleeff
Researcher at Fred Hutchinson Cancer Research Center
Publications - 25
Citations - 5046
Dana Panteleeff is an academic researcher from Fred Hutchinson Cancer Research Center. The author has contributed to research in topics: Viral load & Virus. The author has an hindex of 20, co-authored 25 publications receiving 4669 citations. Previous affiliations of Dana Panteleeff include University of Washington & University of Nairobi.
Papers
More filters
Journal ArticleDOI
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.
Jared M. Baeten,Deborah Donnell,Deborah Donnell,Patrick Ndase,Nelly Mugo,Nelly Mugo,James D. Campbell,Jonathan Wangisi,Jordan W. Tappero,Elizabeth A. Bukusi,Craig R. Cohen,Elly Katabira,Allan R. Ronald,Allan R. Ronald,Elioda Tumwesigye,Edwin Were,Kenneth H. Fife,James Kiarie,James Kiarie,Carey Farquhar,Grace John-Stewart,Aloysious Kakia,Josephine Odoyo,Akasiima Mucunguzi,Edith Nakku-Joloba,Rogers Twesigye,Kenneth Ngure,Cosmas Apaka,Harrison Tamooh,Fridah Gabona,Andrew Mujugira,Dana Panteleeff,Katherine K. Thomas,Lara Kidoguchi,Meighan Krows,Jennifer Revall,Susan Morrison,Harald S. Haugen,Mira Emmanuel-Ogier,Lisa Ondrejcek,Robert W. Coombs,Lisa M. Frenkel,Lisa M. Frenkel,Craig W. Hendrix,Namandjé N. Bumpus,David R. Bangsberg,Jessica E. Haberer,Wendy S. Stevens,Jairam R. Lingappa,Connie Celum +49 more
TL;DR: Oral TDF and TDF-FTC both protect against HIV-1 infection in heterosexual men and women, and both study medications significantly reduced the HIV- 1 incidence among both men andWomen.
Journal ArticleDOI
Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections.
Grace C. John,Ruth Nduati,Dorothy Mbori-Ngacha,Barbra A. Richardson,Dana Panteleeff,Anthony Mwatha,Julie Overbaugh,Job J. Bwayo,Jeckoniah O. Ndinya-Achola,Joan K. Kreiss +9 more
TL;DR: Use of methods that decrease infant exposure to HIV-1 in maternal genital secretions or breast milk may enhance currently recommended perinatal HIV- 1 interventions.
Journal ArticleDOI
Subtypes of Human Immunodeficiency Virus Type 1 and Disease Stage among Women in Nairobi, Kenya
Joel R. Neilson,Grace C. John,Jean K. Carr,Paul Lewis,Joan K. Kreiss,Stephanie Jackson,Ruth Nduati,Dorothy Mbori-Ngacha,Dana Panteleeff,Sharon Bodrug,Christina Giachetti,Martha A. Bott,Barbra A. Richardson,Job J. Bwayo,Jeckoniah O. Ndinya-Achola,Julie Overbaugh,Julie Overbaugh +16 more
TL;DR: The data suggest that women in Kenya who are infected with subtype C viruses are at more advanced stages of immunosuppression than women infected withSubtype A or D, and intersubtype recombinant viral genomes may be very common in Kenya and in other parts of Africa where there are multiple subtypes.
Journal ArticleDOI
Breadth of neutralizing antibody response to human immunodeficiency virus type 1 is affected by factors early in infection but does not influence disease progression.
Anne Piantadosi,Dana Panteleeff,Catherine A. Blish,Jared M. Baeten,Walter Jaoko,R. Scott McClelland,R. Scott McClelland,Julie Overbaugh +7 more
TL;DR: A broad N Ab response results from a high level of antigenic stimulation early in infection, which likely accounts for prior observations that greater NAb response breadth is associated with a higher viral load later in infection.
Journal ArticleDOI
Treatment of cervicitis is associated with decreased cervical shedding of HIV-1.
R S Mcclelland,Chia C. Wang,Kishorchandra Mandaliya,Julie Overbaugh,M T Reiner,Dana Panteleeff,Ludo Lavreys,Jeckoniah O. Ndinya-Achola,Job J. Bwayo,Joan K. Kreiss +9 more
TL;DR: Effective treatment of cervicitis resulted in significant decreases in shedding of HIV-1 virus and infected cells in cervical secretions, indicating that treatment of sexually transmitted diseases may be an important means of decreasing the infectivity of HIV/1 seropositive women by reducing exposure to HIV- 1 in genital secretions.